Modelling study of protein kinase inhibitors: Binding mode of staurosporine and origin of the selectivity of CGP 52411

被引:104
作者
Furet, P
Caravatti, G
Lydon, N
Priestle, JP
Sowadski, JM
Trinks, U
Traxler, P
机构
[1] UNIV CALIF SAN DIEGO,DEPT BIOL,SAN DIEGO,CA 92093
[2] UNIV CALIF SAN DIEGO,DEPT MED,SAN DIEGO,CA 92093
关键词
EGF-receptor kinase; docking; adenosine triphosphate; bioactive conformation; dianilinophthalimides;
D O I
10.1007/BF00124317
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A model for the binding mode of the potent protein kinase inhibitor staurosporine is proposed. Using the information provided by the crystal structure of the cyclic-AMP-dependent protein kinase, it is suggested that staurosporine, despite a seemingly unrelated chemical structure, exploits the same key hydrogen-bond interactions as ATP, the cofactor of the protein kinases, in its binding mode. The structure-activity relationships of the inhibitor and a docking analysis give strong support to this hypothesis. The selectivity of the dianilinophthalimide inhibitor CGP 52411 towards the EGF-receptor protein tyrosine kinase is rationalized on the basis of the model. It is proposed that this selectivity originates in the occupancy, by one of the anilino moieties of the inhibitor, of the region of the enzyme cleft that normally binds the ribose ring of ATP, which appears to possess a marked lipophilic character in this kinase.
引用
收藏
页码:465 / 472
页数:8
相关论文
共 35 条
  • [1] INHIBITORS OF PROTEIN-KINASE-C .3. POTENT AND HIGHLY SELECTIVE BISINDOLYLMALEIMIDES BY CONFORMATIONAL RESTRICTION
    BIT, RA
    DAVIS, PD
    ELLIOTT, LH
    HARRIS, W
    HILL, CH
    KEECH, E
    KUMAR, H
    LAWTON, G
    MAW, A
    NIXON, JS
    VESEY, DR
    WADSWORTH, J
    WILKINSON, SE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (01) : 21 - 29
  • [2] PHOSPHOTRANSFERASE AND SUBSTRATE BINDING MECHANISM OF THE CAMP-DEPENDENT PROTEIN-KINASE CATALYTIC SUBUNIT FROM PORCINE HEART AS DEDUCED FROM THE 2.0 ANGSTROM STRUCTURE OF THE COMPLEX WITH MN2+ ADENYLYL IMIDODIPHOSPHATE AND INHIBITOR PEPTIDE PKI(5-24)
    BOSSEMEYER, D
    ENGH, RA
    KINZEL, V
    PONSTINGL, H
    HUBER, R
    [J]. EMBO JOURNAL, 1993, 12 (03) : 849 - 859
  • [3] 4,5-DIANILINOPHTHALIMIDE - A PROTEIN-TYROSINE KINASE INHIBITOR WITH SELECTIVITY FOR THE EPIDERMAL GROWTH-FACTOR RECEPTOR SIGNAL-TRANSDUCTION PATHWAY AND POTENT IN-VIVO ANTITUMOR-ACTIVITY
    BUCHDUNGER, E
    TRINKS, U
    METT, H
    REGENASS, U
    MULLER, M
    MEYER, T
    MCGLYNN, E
    PINNA, LA
    TRAXLER, P
    LYDON, NB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) : 2334 - 2338
  • [4] INHIBITORY ACTIVITY AND SELECTIVITY OF STAUROSPORINE DERIVATIVES TOWARDS PROTEIN-KINASE-C
    CARAVATTI, G
    MEYER, T
    FREDENHAGEN, A
    TRINKS, U
    METT, H
    FABBRO, D
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (03) : 399 - 404
  • [5] INHIBITORS OF PROTEIN-KINASE-C .2. SUBSTITUTED BISINDOLYMALEIMIDES WITH IMPROVED POTENCY AND SELECTIVITY
    DAVIS, PD
    ELLIOTT, LH
    HARRIS, W
    HILL, CH
    HURST, SA
    KEECH, E
    KUMAR, MKH
    LAWTON, G
    NIXON, JS
    WILKINSON, SE
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (06) : 994 - 1001
  • [6] THE DESIGN OF INHIBITORS OF PROTEIN-KINASE-C - THE SOLUTION CONFORMATION OF STAUROSPORINE
    DAVIS, PD
    HILL, CH
    THOMAS, WA
    WHITCOMBE, IWA
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1991, (03) : 182 - 184
  • [7] CRYSTAL-STRUCTURE OF CYCLIN-DEPENDENT KINASE-2
    DEBONDT, HL
    ROSENBLATT, J
    JANCARIK, J
    JONES, HD
    MORGAN, DO
    KIM, SH
    [J]. NATURE, 1993, 363 (6430) : 595 - 602
  • [8] DOW RL, 1994, CURR MED CHEM, V1, P192
  • [10] ABSOLUTE-CONFIGURATION OF STAUROSPORINE BY X-RAY-ANALYSIS
    FUNATO, N
    TAKAYANAGI, H
    KONDA, Y
    TODA, Y
    HARIGAYA, Y
    IWAI, Y
    OMURA, S
    [J]. TETRAHEDRON LETTERS, 1994, 35 (08) : 1251 - 1254